TENAX THERAPEUTICS INC (TENX) Stock Earnings & Estimates
USA - NASDAQ:TENX - US88032L6056 - Common Stock
7.285 USD
+0.03 (+0.34%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 290K | N/A -100.00% | 47.607M | 173.52M 264.48% | 310.16M 78.75% | 464.98M 49.92% | 661.46M 42.26% | |||||||||||||
| EBITDA YoY % growth | -16.46M | N/A 36.85% | N/A -86.32% | N/A 52.54% | N/A 25.11% | N/A -24.20% | -9.078M -15.36% | N/A -231.76% | -11.736M 66.24% | -15.116M 25.54% | -20.056M -136.97% | -24.545M -25.91% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -16.61M | N/A 37.23% | N/A -85.94% | -9.792M 52.51% | -6.936M 25.12% | -8.415M -24.11% | -9.078M -15.34% | -34.221M -231.66% | -12.6M 66.23% | -7.535M 25.50% | -18.043M -136.75% | -54.905M -181.65% | -68.109M -24.05% | -69.326M -1.79% | -8.786M 87.33% | 102.67M 1,268.57% | 188.39M 83.49% | 287.04M 52.36% | 226.24M -21.18% | |
| Operating Margin | -5,727.59% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -18.46% | 59.17% | 60.74% | 61.73% | 34.20% | |
| EPS YoY % growth | N/A | N/A | -21,216.00 | -11,424.00 17.50% | -6,780.96 32.41% | -2,537.76 68.15% | -1,379.04 -2.96% | -2,652.00 -38.85% | -759.70 75.40% | -29.38 95.34% | -2.33 84.96% | -1.26 76.32% | -1.44 -14.17% | -1.41 2.30% | -1.44 -2.36% | -0.16 88.65% | 2.18 1,437.50% | 5.20 138.32% | 8.33 60.20% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.32 -67.76% | -0.37 -108.25% | -0.38 -36.61% | -0.39 -43.56% | -0.32 0.80% | -0.32 15.65% | -0.33 14.67% | -0.34 13.16% | -0.36 -12.90% | -0.39 -22.58% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -14.405M -211.88% | -16.913M -131.85% | -17.917M -58.03% | -18.097M -53.47% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.27 85.25% | -0.24 | -0.03 | -10.29% |
| Q1 2025 Q2Q % growth | -0.28 91.03% | -0.20 | -0.08 | -41.99% |
| Q4 2024 Q2Q % growth | -0.18 98.61% | -0.43 | 0.25 | 58.23% |
| Q3 2024 Q2Q % growth | -0.19 97.03% | -1.42 | 1.23 | 86.60% |
| Q2 2024 Q2Q % growth | -1.83 54.25% | -2.02 | 0.19 | 9.62% |
| Q1 2024 Q2Q % growth | -3.12 74.00% | -2.45 | -0.67 | -27.45% |
| Q4 2023 Q2Q % growth | -12.98 90.62% | -8.31 | -4.67 | -56.24% |
| Q3 2023 Q2Q % growth | -6.40 96.36% | -7.34 | 0.94 | 12.85% |
| Q2 2023 Q2Q % growth | -4.00 97.73% | -8.16 | 4.16 | 50.98% |
| Q1 2023 Q2Q % growth | -12.00 -10,595.19% | -30.19 | 18.19 | 60.25% |
| Q4 2022 Q2Q % growth | -138.40 -116.25% | -186.05 | 47.65 | 25.61% |
| Q3 2022 Q2Q % growth | -176.00 26.67% | -171.36 | -4.64 | -2.71% |
| Q2 2022 Q2Q % growth | -176.00 -10.00% | -146.88 | -29.12 | -19.83% |
| Q1 2022 Q2Q % growth | 100.00% | -0.11 | % | |
| Q4 2021 Q2Q % growth | -64.00 93.33% | -261.12 | 197.12 | 75.49% |
| Q3 2021 Q2Q % growth | -240.00 16.67% | -212.16 | -27.84 | -13.12% |
| Q2 2021 Q2Q % growth | -160.00 56.52% | -212.16 | 52.16 | 24.59% |
| Q1 2021 Q2Q % growth | -2,624.00 -331.58% | -342.72 | -2,281.28 | -665.64% |
| Q4 2020 Q2Q % growth | -960.00 -46.34% | -228.48 | -731.52 | -320.17% |
| Q3 2020 Q2Q % growth | -288.00 45.45% | -236.64 | -51.36 | -21.70% |
| Q2 2020 Q2Q % growth | -368.00 17.86% | -342.72 | -25.28 | -7.38% |
| Q1 2020 Q2Q % growth | -608.00 -15.15% | -310.08 | -297.92 | -96.08% |
| Q4 2019 Q2Q % growth | -656.00 | -987.36 | 331.36 | 33.56% |
| Q3 2019 Q2Q % growth | -528.00 | -612.00 | 84.00 | 13.73% |
| Q2 2019 Q2Q % growth | -448.00 | -660.96 | 212.96 | 32.22% |
| Q1 2019 Q2Q % growth | -528.00 | -554.88 | 26.88 | 4.84% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.9% | -20.19% | -1.79% | -14.71% |
| Revenue | N/A | N/A | N/A | N/A |